{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:43:50Z","timestamp":1790808230647,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,23]]},"DOI":"10.7759\/cureus.84687","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T15:23:19Z","timestamp":1748013799000},"source":"Crossref","is-referenced-by-count":7,"title":["Gut Microbiota as a Key Modulator of Chronic Disease: Implications for Diabetes, Autoimmunity, and Cancer"],"prefix":"10.7759","author":[{"given":"Noor","family":"Inayat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Zahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad J","family":"Hashmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenal","family":"Sikander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Zakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabeena","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saira K","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed S","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090849","article-title":"Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer","volume":"9","author":"Zhu Q","year":"2014","unstructured":"Zhu Q, Jin Z, Wu W, et al.. Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS One. 2014, 9:e90849. 10.1371\/journal.pone.0090849","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.682721","article-title":"A metagenome-wide association study of the gut microbiome and metabolic syndrome","volume":"12","author":"Qin Q","year":"2021","unstructured":"Qin Q, Yan S, Yang Y, et al.. A metagenome-wide association study of the gut microbiome and metabolic syndrome. Front Microbiol. 2021, 12:682721. 10.3389\/fmicb.2021.682721","journal-title":"Front Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1101\/gr.126573.111","article-title":"Genomic analysis identifies association of Fusobacterium with colorectal carcinoma","volume":"22","author":"Kostic AD","year":"2012","unstructured":"Kostic AD, Gevers D, Pedamallu CS, et al.. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012, 22:292-8. 10.1101\/gr.126573.111","journal-title":"Genome Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4161\/gmic.19320","article-title":"The role of gut microbiota in immune homeostasis and autoimmunity","volume":"3","author":"Wu HJ","year":"2012","unstructured":"Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes. 2012, 3:4-14. 10.4161\/gmic.19320","journal-title":"Gut Microbes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-306928","article-title":"Microbiota and diabetes: an evolving relationship","volume":"63","author":"Tilg H","year":"2014","unstructured":"Tilg H, Moschen AR. Microbiota and diabetes: an evolving relationship. Gut. 2014, 63:1513-21. 10.1136\/gutjnl-2014-306928","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3610","article-title":"The microbiome and cancer","volume":"13","author":"Schwabe RF","year":"2013","unstructured":"Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer. 2013, 13:800-12. 10.1038\/nrc3610","journal-title":"Nat Rev Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid Y","year":"2014","unstructured":"Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014, 157:121-41. 10.1016\/j.cell.2014.03.011","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309990","article-title":"The gut microbiota and host health: a new clinical frontier","volume":"65","author":"Marchesi JR","year":"2016","unstructured":"Marchesi JR, Adams DH, Fava F, et al.. The gut microbiota and host health: a new clinical frontier. Gut. 2016, 65:330-9. 10.1136\/gutjnl-2015-309990","journal-title":"Gut"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000139","article-title":"The gut microbiome in health and in disease","volume":"31","author":"Shreiner AB","year":"2015","unstructured":"Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Curr Opin Gastroenterol. 2015, 31:69-75. 10.1097\/MOG.0000000000000139","journal-title":"Curr Opin Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge C","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019, 4:5. 10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/9781118982907.ch1","article-title":"Chapter 1: The human microbiota and chronic disease: dysbiosis as a cause of human pathology","author":"Wilson M","year":"2016","unstructured":"Wilson M. Chapter 1: The human microbiota and chronic disease: dysbiosis as a cause of human pathology. The Human Microbiota and Chronic Disease: Dysbiosis as a Cause of Human Pathology. Nibali L, Henderson B (ed): Wiley Blackwell, Hoboken; 2016. 10.1002\/9781118982907.ch1"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11081994","article-title":"Antonie van Leeuwenhoek (1632-1723): master of fleas and father of microbiology","volume":"11","author":"Kutschera U","year":"2023","unstructured":"Kutschera U. Antonie van Leeuwenhoek (1632-1723): master of fleas and father of microbiology. Microorganisms. 2023, 11:10.3390\/microorganisms11081994","journal-title":"Microorganisms"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1101\/gr.096651.109","article-title":"The NIH Human Microbiome Project","volume":"19","author":"Peterson J","year":"2009","unstructured":"Peterson J, Garges S, Giovanni M, et al.. The NIH Human Microbiome Project. Genome Res. 2009, 19:2317-23. 10.1101\/gr.096651.109","journal-title":"Genome Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/731685","article-title":"Beyond obesity and lifestyle: a review of 21st century chronic disease determinants","volume":"2014","author":"Egger G","year":"2014","unstructured":"Egger G, Dixon J. Beyond obesity and lifestyle: a review of 21st century chronic disease determinants. Biomed Res Int. 2014, 2014:731685. 10.1155\/2014\/731685","journal-title":"Biomed Res Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2023.2213112","article-title":"The interplay between oral microbiota, gut microbiota and systematic diseases","volume":"15","author":"Tan X","year":"2023","unstructured":"Tan X, Wang Y, Gong T. The interplay between oral microbiota, gut microbiota and systematic diseases. J Oral Microbiol. 2023, 15:2213112. 10.1080\/20002297.2023.2213112","journal-title":"J Oral Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1017\/gmb.2020.2","article-title":"The role of probiotics on the roadmap to a healthy microbiota: a symposium report","volume":"1","author":"Lockyer S","year":"2020","unstructured":"Lockyer S, Aguirre M, Durrant L, Pot B, Suzuki K. The role of probiotics on the roadmap to a healthy microbiota: a symposium report. Gut Microbiome (Camb). 2020, 1:e2. 10.1017\/gmb.2020.2","journal-title":"Gut Microbiome (Camb)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v11.i7.293","article-title":"Gut microbiota and diabetes: from correlation to causality and mechanism","volume":"11","author":"Li WZ","year":"2020","unstructured":"Li WZ, Stirling K, Yang JJ, Zhang L. Gut microbiota and diabetes: from correlation to causality and mechanism. World J Diabetes. 2020, 11:293-308. 10.4239\/wjd.v11.i7.293","journal-title":"World J Diabetes"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000483","article-title":"The gut microbiota in type 1 diabetes: friend or foe?","volume":"26","author":"Gavin PG","year":"2019","unstructured":"Gavin PG, Hamilton-Williams EE. The gut microbiota in type 1 diabetes: friend or foe?. Curr Opin Endocrinol Diabetes Obes. 2019, 26:207-12. 10.1097\/MED.0000000000000483","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i6.730","article-title":"Mechanisms linking gut microbial metabolites to insulin resistance","volume":"12","author":"Jang HR","year":"2021","unstructured":"Jang HR, Lee HY. Mechanisms linking gut microbial metabolites to insulin resistance. World J Diabetes. 2021, 12:730-44. 10.4239\/wjd.v12.i6.730","journal-title":"World J Diabetes"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00041.2015","article-title":"Linking gut microbiota and inflammation to obesity and insulin resistance","volume":"31","author":"Saad MJ","year":"2016","unstructured":"Saad MJ, Santos A, Prada PO. Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology (Bethesda). 2016, 31:283-93. 10.1152\/physiol.00041.2015","journal-title":"Physiology (Bethesda)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-023-00565-3","article-title":"Gut microbiota modulation and its implications on neuropathic pain: a comprehensive literature review","volume":"13","author":"Corriero A","year":"2024","unstructured":"Corriero A, Giglio M, Inchingolo F, Moschetta A, Varrassi G, Puntillo F. Gut microbiota modulation and its implications on neuropathic pain: a comprehensive literature review. Pain Ther. 2024, 13:33-51. 10.1007\/s40122-023-00565-3","journal-title":"Pain Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666171009121702","article-title":"Gut microbiota as a therapeutic target for metabolic disorders","volume":"25","author":"Okubo H","year":"2018","unstructured":"Okubo H, Nakatsu Y, Kushiyama A, et al.. Gut microbiota as a therapeutic target for metabolic disorders. Curr Med Chem. 2018, 25:984-1001. 10.2174\/0929867324666171009121702","journal-title":"Curr Med Chem"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/nu15235005","article-title":"The beneficial effects of dietary interventions on gut microbiota-an up-to-date critical review and future perspectives","volume":"15","author":"Purdel C","year":"2023","unstructured":"Purdel C, Margin\u0103 D, Adam-Dima I, Ungurianu A. The beneficial effects of dietary interventions on gut microbiota-an up-to-date critical review and future perspectives. Nutrients. 2023, 15:10.3390\/nu15235005","journal-title":"Nutrients"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26196076","article-title":"Probiotics regulate gut microbiota: an effective method to improve immunity","volume":"26","author":"Wang X","year":"2021","unstructured":"Wang X, Zhang P, Zhang X. Probiotics regulate gut microbiota: an effective method to improve immunity. Molecules. 2021, 26:10.3390\/molecules26196076","journal-title":"Molecules"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116022","article-title":"Effects of probiotics on gut microbiota: an overview","volume":"25","author":"Chandrasekaran P","year":"2024","unstructured":"Chandrasekaran P, Weiskirchen S, Weiskirchen R. Effects of probiotics on gut microbiota: an overview. Int J Mol Sci. 2024, 25:10.3390\/ijms25116022","journal-title":"Int J Mol Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-024-00602-9","article-title":"Microbial symphony: exploring the role of the gut in osteoarthritis-related pain. A narrative review","volume":"13","author":"Corriero A","year":"2024","unstructured":"Corriero A, Giglio M, Soloperto R, Inchingolo F, Varrassi G, Puntillo F. Microbial symphony: exploring the role of the gut in osteoarthritis-related pain. A narrative review. Pain Ther. 2024, 13:409-33. 10.1007\/s40122-024-00602-9","journal-title":"Pain Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2018.08.011","article-title":"Fecal microbiota transplantation: review and update","volume":"118 Suppl 1","author":"Wang JW","year":"2019","unstructured":"Wang JW, Kuo CH, Kuo FC, et al.. Fecal microbiota transplantation: review and update. J Formos Med Assoc. 2019, 118 Suppl 1:S23-31. 10.1016\/j.jfma.2018.08.011","journal-title":"J Formos Med Assoc"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1365554","article-title":"Emerging role of gut microbiota in autoimmune diseases","volume":"15","author":"Wang X","year":"2024","unstructured":"Wang X, Yuan W, Yang C, et al.. Emerging role of gut microbiota in autoimmune diseases. Front Immunol. 2024, 15:1365554. 10.3389\/fimmu.2024.1365554","journal-title":"Front Immunol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00727-y","article-title":"The impact of the gut microbiome on extra-intestinal autoimmune diseases","volume":"23","author":"Miyauchi E","year":"2023","unstructured":"Miyauchi E, Shimokawa C, Steimle A, Desai MS, Ohno H. The impact of the gut microbiome on extra-intestinal autoimmune diseases. Nat Rev Immunol. 2023, 23:9-23. 10.1038\/s41577-022-00727-y","journal-title":"Nat Rev Immunol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxac057","article-title":"Gut microbiome and autoimmune disorders","volume":"209","author":"Shaheen WA","year":"2022","unstructured":"Shaheen WA, Quraishi MN, Iqbal TH. Gut microbiome and autoimmune disorders. Clin Exp Immunol. 2022, 209:161-74. 10.1093\/cei\/uxac057","journal-title":"Clin Exp Immunol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8101587","article-title":"Gut microbiota and immune system interactions","volume":"8","author":"Yoo JY","year":"2020","unstructured":"Yoo JY, Groer M, Dutra SV, Sarkar A, McSkimming DI. Gut microbiota and immune system interactions. Microorganisms. 2020, 8:10.3390\/microorganisms8101587","journal-title":"Microorganisms"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.05.014","article-title":"Immune-microbiota interactions in health and disease","volume":"159","author":"Palm NW","year":"2015","unstructured":"Palm NW, de Zoete MR, Flavell RA. Immune-microbiota interactions in health and disease. Clin Immunol. 2015, 159:122-7. 10.1016\/j.clim.2015.05.014","journal-title":"Clin Immunol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1007165","article-title":"Gut microbiota and rheumatoid arthritis: from pathogenesis to novel therapeutic opportunities","volume":"13","author":"Zhao T","year":"2022","unstructured":"Zhao T, Wei Y, Zhu Y, Xie Z, Hai Q, Li Z, Qin D. Gut microbiota and rheumatoid arthritis: from pathogenesis to novel therapeutic opportunities. Front Immunol. 2022, 13:1007165. 10.3389\/fimmu.2022.1007165","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01202","article-title":"Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis","volume":"2","author":"Scher JU","year":"2013","unstructured":"Scher JU, Sczesnak A, Longman RS, et al.. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife. 2013, 2:e01202. 10.7554\/eLife.01202","journal-title":"Elife"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-022-00697-8","article-title":"The role of the gut microbiota in multiple sclerosis","volume":"18","author":"Correale J","year":"2022","unstructured":"Correale J, Hohlfeld R, Baranzini SE. The role of the gut microbiota in multiple sclerosis. Nat Rev Neurol. 2022, 18:544-58. 10.1038\/s41582-022-00697-8","journal-title":"Nat Rev Neurol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01081","article-title":"Modulation of multiple sclerosis and its animal model experimental autoimmune encephalomyelitis by food and gut microbiota","volume":"8","author":"van den Hoogen WJ","year":"2017","unstructured":"van den Hoogen WJ, Laman JD, 't Hart BA. Modulation of multiple sclerosis and its animal model experimental autoimmune encephalomyelitis by food and gut microbiota. Front Immunol. 2017, 8:1081. 10.3389\/fimmu.2017.01081","journal-title":"Front Immunol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01148-1","article-title":"The gut microbiota in multiple sclerosis varies with disease activity","volume":"15","author":"Thirion F","year":"2023","unstructured":"Thirion F, Sellebjerg F, Fan Y, et al.. The gut microbiota in multiple sclerosis varies with disease activity. Genome Med. 2023, 15:1. 10.1186\/s13073-022-01148-1","journal-title":"Genome Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20054624","article-title":"Changes in gut microbiota and multiple sclerosis: a systematic review","volume":"20","author":"Ordo\u00f1ez-Rodriguez A","year":"2023","unstructured":"Ordo\u00f1ez-Rodriguez A, Roman P, Rueda-Ruzafa L, Campos-Rios A, Cardona D. Changes in gut microbiota and multiple sclerosis: a systematic review. Int J Environ Res Public Health. 2023, 20:10.3390\/ijerph20054624","journal-title":"Int J Environ Res Public Health"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.733992","article-title":"The gut microbiota in inflammatory bowel disease","volume":"12","author":"Qiu P","year":"2022","unstructured":"Qiu P, Ishimoto T, Fu L, Zhang J, Zhang Z, Liu Y. The gut microbiota in inflammatory bowel disease. Front Cell Infect Microbiol. 2022, 12:733992. 10.3389\/fcimb.2022.733992","journal-title":"Front Cell Infect Microbiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042320-021020","article-title":"The gut microbiome and inflammatory bowel diseases","volume":"73","author":"Shan Y","year":"2022","unstructured":"Shan Y, Lee M, Chang EB. The gut microbiome and inflammatory bowel diseases. Annu Rev Med. 2022, 73:455-68. 10.1146\/annurev-med-042320-021020","journal-title":"Annu Rev Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-321153","article-title":"The role of gut microbiota in cancer treatment: friend or foe?","volume":"69","author":"Cheng WY","year":"2020","unstructured":"Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: friend or foe?. Gut. 2020, 69:1867-76. 10.1136\/gutjnl-2020-321153","journal-title":"Gut"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00513-x","article-title":"Targeting the gut microbiota for cancer therapy","volume":"22","author":"Fernandes MR","year":"2022","unstructured":"Fernandes MR, Aggarwal P, Costa RG, Cole AM, Trinchieri G. Targeting the gut microbiota for cancer therapy. Nat Rev Cancer. 2022, 22:703-22. 10.1038\/s41568-022-00513-x","journal-title":"Nat Rev Cancer"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2017.06.002","article-title":"Human gut microbiota and gastrointestinal cancer","volume":"16","author":"Meng C","year":"2018","unstructured":"Meng C, Bai C, Brown TD, Hood LE, Tian Q. Human gut microbiota and gastrointestinal cancer. Genomics Proteomics Bioinformatics. 2018, 16:33-49. 10.1016\/j.gpb.2017.06.002","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14122964","article-title":"Implications of gut microbiota in epithelial-mesenchymal transition and cancer progression: a concise review","volume":"14","author":"Gupta I","year":"2022","unstructured":"Gupta I, Pedersen S, Vranic S, Al Moustafa AE. Implications of gut microbiota in epithelial-mesenchymal transition and cancer progression: a concise review. Cancers (Basel). 2022, 14:10.3390\/cancers14122964","journal-title":"Cancers (Basel)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02554-x","article-title":"Intratumoral presence of the genotoxic gut bacteria pks(+) E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer","volume":"130","author":"Joo JE","year":"2024","unstructured":"Joo JE, Chu YL, Georgeson P, et al.. Intratumoral presence of the genotoxic gut bacteria pks(+) E. coli, Enterotoxigenic Bacteroides fragilis, and Fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer. Br J Cancer. 2024, 130:728-40. 10.1038\/s41416-023-02554-x","journal-title":"Br J Cancer"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1762520","article-title":"The role of gastric microbiota in gastric cancer","volume":"11","author":"Stewart OA","year":"2020","unstructured":"Stewart OA, Wu F, Chen Y. The role of gastric microbiota in gastric cancer. Gut Microbes. 2020, 11:1220-30. 10.1080\/19490976.2020.1762520","journal-title":"Gut Microbes"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1183331","article-title":"The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy","volume":"14","author":"Wang M","year":"2023","unstructured":"Wang M, Yang G, Tian Y, Zhang Q, Liu Z, Xin Y. The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy. Front Immunol. 2023, 14:1183331. 10.3389\/fimmu.2023.1183331","journal-title":"Front Immunol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104709","article-title":"Dysbiosis of gut microbiota in patients with esophageal cancer","volume":"150","author":"Deng Y","year":"2021","unstructured":"Deng Y, Tang D, Hou P, Shen W, Li H, Wang T, Liu R. Dysbiosis of gut microbiota in patients with esophageal cancer. Microb Pathog. 2021, 150:104709. 10.1016\/j.micpath.2020.104709","journal-title":"Microb Pathog"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1057668","article-title":"Esophageal cancer and bacterial part of gut microbiota - a multidisciplinary point of view","volume":"12","author":"Muszy\u0144ski D","year":"2022","unstructured":"Muszy\u0144ski D, Kudra A, Sobocki BK, et al.. Esophageal cancer and bacterial part of gut microbiota - a multidisciplinary point of view. Front Cell Infect Microbiol. 2022, 12:1057668. 10.3389\/fcimb.2022.1057668","journal-title":"Front Cell Infect Microbiol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2240031","article-title":"Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions","volume":"15","author":"Rajapakse J","year":"2023","unstructured":"Rajapakse J, Khatiwada S, Akon AC, Yu KL, Shen S, Zekry A. Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions. Gut Microbes. 2023, 15:2240031. 10.1080\/19490976.2023.2240031","journal-title":"Gut Microbes"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15142","article-title":"Gut-liver axis-mediated mechanism of liver cancer: a special focus on the role of gut microbiota","volume":"112","author":"Ohtani N","year":"2021","unstructured":"Ohtani N, Hara E. Gut-liver axis-mediated mechanism of liver cancer: a special focus on the role of gut microbiota. Cancer Sci. 2021, 112:4433-43. 10.1111\/cas.15142","journal-title":"Cancer Sci"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.37349\/ei.2025.1003178","article-title":"The putative role of immune-inflammatory mechanisms in nociplastic pain pathways: a narrative review","volume":"5","author":"Giglio M","year":"2025","unstructured":"Giglio M, Corriero A, Preziosa A, et al.. The putative role of immune-inflammatory mechanisms in nociplastic pain pathways: a narrative review. Exploration Immunol. 2025, 5:1003178. 10.37349\/ei.2025.1003178","journal-title":"Exploration Immunol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01338-6","article-title":"Influence of microbiota on NSAID enteropathy: a systematic review of current knowledge and the role of probiotics","volume":"37","author":"Rekatsina M","year":"2020","unstructured":"Rekatsina M, Paladini A, Cifone MG, Lombardi F, Pergolizzi JV, Varrassi G. Influence of microbiota on NSAID enteropathy: a systematic review of current knowledge and the role of probiotics. Adv Ther. 2020, 37:1933-45. 10.1007\/s12325-020-01338-6","journal-title":"Adv Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/357201-gut-microbiota-as-a-key-modulator-of-chronic-disease-implications-for-diabetes-autoimmunity-and-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T15:23:19Z","timestamp":1748013799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/357201-gut-microbiota-as-a-key-modulator-of-chronic-disease-implications-for-diabetes-autoimmunity-and-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7759\/cureus.84687","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}